Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 Nivolumab Monotherapy in Relapsed/Refractory PCNSL or PTL
jRCT2080223347Phase 2Completed
- Sponsor
- Ono Pharmaceutical
- Start
- Oct 2016
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
01
Overview
Phase 2, open-label trial of nivolumab in primary central nervous system lymphoma (PCNSL) and testicular lymphoma (PTL) (2 cohorts), sponsored by Ono Pharmaceutical. Started Oct 2016; status: completed.
02
Drugs
03
Conditions
primary central nervous system lymphoma (PCNSL)testicular lymphoma (PTL)
Beyond the preview
Go deeper on jRCT2080223347.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223347.